1 in 5 young people turn to AI chatbots for mental health support

By FOX 5 DC · June 25, 2026.

A recent study has put numbers to a trend that many mental health professionals already suspected: 1 in 5 young people has turned to artificial intelligence chatbots to seek emotional or psychological support. The figure was presented on June 25, 2026, on FOX 5's Good Day DC program, with the participation of Dr. Jessica Watrous, Chief Clinical Officer of the digital mental health platform Modern Health.

The FOX 5 DC article is based on a video segment and does not lay out the full content of the interview in text, so the methodological details of the study —authorship, sample size, the age range considered 'young,' or additional conclusions— are not available in the published material. What is on record is the central finding: AI's penetration as a mental health resource among young people now reaches one in five people.

Modern Health is a U.S. company that offers mental health services through employers, combining human therapy with digital tools. The presence of its chief clinical officer on a regional outlet like FOX 5 DC suggests an industry effort to position itself in the public debate over the use of AI in contexts as sensitive as emotional health.

As sector context, the surge of conversational chatbots —both general-purpose ones such as ChatGPT or Gemini, and mental-health-specific niche ones such as Woebot or Wysa— has sparked an intense debate among clinicians, regulators and technologists. Supporters point to accessibility (24/7 availability, zero or low cost, no perceived stigma) as key advantages for populations that would otherwise not access care. Critics warn of risks such as the lack of clinical oversight, the possibility that the chatbot provides inadequate responses during acute crises, or that it generates emotional dependence in vulnerable users.

The 1-in-5 figure for young people is significant because it suggests that adoption is no longer marginal, but has become a widespread practice among the generation that grew up with smartphones and voice assistants. This demographic shows greater comfort interacting with AI systems and less reluctance to share personal information with digital interfaces than with human professionals.

From the perspective of agentic AI —systems capable of acting autonomously, maintaining context over time and taking initiative without explicit instruction at every step—, mental health is one of the most complex and highest-risk domains. An AI agent that remembers a user's emotional history, detects patterns of deterioration and proposes preventive interventions has enormous therapeutic potential, but it also raises questions with no definitive regulatory answer: who is responsible if the agent fails to detect suicidal ideation? How is the reasoning of a system that operates continuously and autonomously audited?

In general, European regulation (the EU AI Act) classifies AI systems for mental health in the high-risk category when used for diagnosis or treatment, which entails obligations of transparency, human oversight and conformity assessment. In the United States, the FDA has begun to publish guidance on medical device software that includes AI features, although the framework is still evolving.

The fact that a platform like Modern Health —which combines humans and AI— occupies media space to comment on these figures also points to a commercial opportunity: positioning itself as the 'responsible' model versus the unsupervised use of general-purpose chatbots. The distinction between an AI chatbot integrated into a clinical ecosystem with professional oversight and the use of ChatGPT or similar tools to talk about anxiety is relevant both clinically and from a regulatory standpoint, although for the young user that boundary may be invisible.

In short, the FOX 5 DC segment provides a concrete figure —1 in 5 young people— that reflects a massive and rapid adoption of AI as an informal mental health resource. The coverage is sparse on additional detail, but the number alone foreshadows growing debates over clinical oversight, legal liability and the ethical design of AI systems in one of the most delicate areas of human health.